Endocrine Research Updates
For Medical Professionals
To most effectively reverse undesirable body weight in children, clinicians will need to employ a multifaceted approach of diet, physical activity, behavior modification, and education, involving the entire family.
Tackling common reasons for both patient and clinician resistance to using the latest devices that promise more effective diabetes management and improved health outcomes.
Researchers sought to determine if the use of a computerized system would virtually allow for improved identification of pediatric patients at high risk for prediabetes and type 2 diabetes
Mayo Clinic Study found that RAI was favored over antithyroid medications and thyroidectomy, offering the best outcome for this most common form of hyperthyroid disease, among this group of patients.
EndocrineWeb highlights results of the last 2 of 7 studies—looking at the effects of testosterone replacement for anemia and bone strength in older men with low circulating hormone levels—from the National Institutes of Health (NIH) sponsored Testosterone Trials (TTrials).
Seeking confirmation of efficacy, results from 2 of the 4 testosterone trials (TTrials) are highlighted to address the growing practice of boosting low testosterone in men. This brief focuses on the findings of testosterone supplementation to achieve improved outcomes in Alzheimer’s disease and cardiovascular disease.
To assess for factors that might predict relapse of hyperthyroidism, a meta-analysis was conducted encompassing studies published over four decades.
Individualizing care, rather than following guidelines and clinical recommendations uncritically, will improve disease management and reduce costs without compromising outcomes, according to researchers who evaluated current practice.
Updated position statement issued by the American Diabetes Association for managing diabetic neuropathies focused on preventing and early screening as the primary goals.
DNA methylation may join body mass index, adiposity, and gene expression as another factor that predisposes certain individuals to develop obesity, obesity-related conditions.
Pediatric Endocrine Society offers updated recommendations for use of growth-promoting hormone therapy and related medications in children.
85% of patients with type 2 diabetes who received concurrent treatment with exenatide and pioglitazone achieved the ADA-recommended HBA1c goal of <7.0%, with fewer hypoglycemic incidents and less weight gain, achieving clinically improved outcomes over patients taking insulin.
Women can reduce their risk of diabetes and other chronic conditions simply by incorporating resistance exercise into a weekly physical activity plan, according to the National Institute on Aging.
Given the strength of the findings, people who take metformin for their diabetes appear to have an enriched gut microflora that fosters a more efficient response to glucose metabolism.
Lack of training for gender-affirming patients identified; medical interventions, while not complex, require more than simply giving estrogen or testosterone.
Evaluating levels of autotaxin, an enzyme found in the fluid around the brain and spine, may be useful in identifying those at risk of cognitive decline and type 2 diabetes, Iowa researchers find.
The 2017 guidelines, issued after 6 years of new evidence and experience, offer more targeted recommendations for clinical management of women who have thyroid disease once they become pregnant as well as postpartum. Four key changes in the new guidelines are highlighted.
Elevating the accuracy of biopsy node assessment using an oncogene panel and testing for miRNA gene expression
Improving sleep by adjusting work-shifts to fit a person's chronotype may be the most effective approach to address resistant diabetes or creeping obesity.
To provide the most effective care for patients with diabetes, EndocrineWeb editorial board members consider the barriers to care from individualized care planning and a change to prevention over fee-for-serve care, to integrating obesity strategies into diabetes management.
